This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Skrepnek, Grant
Item Type | Name |
Concept
|
Cost-Benefit Analysis
|
Concept
|
Costs and Cost Analysis
|
Concept
|
Cost of Illness
|
Concept
|
Health Care Costs
|
Concept
|
Drug Costs
|
Concept
|
Hospital Costs
|
Academic Article
|
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
|
Academic Article
|
The cost-effectiveness of sertraline in the treatment of depression.
|
Academic Article
|
Health care expenditures, hospitalizations, and productivity associated with cancer in US employer settings.
|
Academic Article
|
Is scorpion antivenom cost-effective as marketed in the United States?
|
Academic Article
|
Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma.
|
Academic Article
|
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
|
Academic Article
|
Regression methods in the empiric analysis of health care data.
|
Academic Article
|
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
|
Academic Article
|
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.
|
Academic Article
|
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs.
|
Academic Article
|
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010.
|
Academic Article
|
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
|
Academic Article
|
Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach.
|
Academic Article
|
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.
|
Academic Article
|
Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies.
|
Academic Article
|
Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001-2010.
|
Academic Article
|
Foot-in-wallet disease: tripped up by "cost-saving" reductions?
|
Academic Article
|
Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost.
|
Academic Article
|
Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: comparison in a decision analysis model.
|
Academic Article
|
Cost-effectiveness of HMG-CoA reductase inhibitors in the treatment of dyslipidemia and prevention of CHD.
|
Academic Article
|
A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010.
|
Academic Article
|
State Medicaid Programs Bring Managed Care Tenets to Fee for Service.
|
Academic Article
|
Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia.
|
Academic Article
|
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation.
|